Clinical trial
Investigational Drug in Patients With Hypercholesterolemia or in Patients With…
NCT00092833 · Organon and Co, Industry · Terminated
Key facts
| NCT number | NCT00092833 |
|---|---|
| Title | Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED) |
| Official title | An Open-Label, Worldwide, Treatment Use Study to Provide Ezetimibe 10 Mg/Day to Patients With Homozygous Familial Hypercholesterolemia or Homozygous Sitosterolemia |
| Lead sponsor | Organon and Co, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Familial, Lipid Metabolism, Inborn Errors |
| Intervention type | Drug |
| Interventions | Comparator: ezetimibe |
| Enrollment | 49 |
| Start date | Jul 1, 2002 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Sep 28, 2004 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: